PRODUCTS
Contact Us
Fax: +86-572-5520251
E-mail: bgs@kangrunpharm.com
Website: www.marysuemcclurkin.com
APIs:
+86-571-88171452
Preparation products:
TOC:+86-571-88175434
Rx Drug:+86-571-88175190
GMed:+86-571-88176600
Fax:+86-571-88176296
Temsirolimus
[Chemical structure]
[Chemical molecular formula] C56H87NO16
[ Molecular weight] 1030.28
[CAS No.] 162635-04-3
[Product specification] Enterprise standard
[Description]
Temsirolimus is an inhibitor of mTOR (mammalian target of rapamycin). Temsirolimus binds to an intracellular protein(FKBP-12), and the protein-drug complex inhibits the activity of mTOR that controls cell division. Inhibition of mTOR activity resulted in a G1 growth arrest in treated tumor cells. When mTOR was inhibited, its ability to phosphorylate p70S6k and S6 ribosomal protein, which are downstream of mTOR in the PI3 kinase/AKT pathway was blocked. In in vitro studies using renal cell carcinoma cell lines, temsirolimus inhibited the activity of mTOR and resulted in reduced levels of the hypoxia-inducible factors HIF-1 and HIF-2 alpha, and the vascular endothelial growth factor.